Health Technology Collaboration | Tissuepathology.com

Techcyte and elea Bring AI-Native Pathology Reporting into Techcyte FusionⓇ

Erica Goodpaster — Fri, 14 Aug 2026 12:23:46 +0000

The partnership brings elea’s pathology-specific AI directly into Techcyte Fusion, enabling pathologists to turn assessments into structured, coded reports. OREM, UT, UNITED STATES, August 13, 2026 /EINPresswire.com/ — Techcyte today announced the availability of eleaDNAi, elea’s AI-native pathology reporting technology, into Techcyte Fusion®, the digital pathology platform that brings anatomic and clinical pathology into a […]

The post Techcyte and elea Bring AI-Native Pathology Reporting into Techcyte FusionⓇ first appeared on Tissuepathology.com.

Aiforia: Unlocking diagnostic value at Fimlab with Aiforia® Breast Cancer Suite

Erica Goodpaster — Wed, 05 Aug 2026 13:12:53 +0000

From the Aiforia blog: In modern clinical pathology, adopting artificial intelligence (AI) is no longer just about algorithm accuracy. A key success factor is seamless workflow integration. Pathology departments manage high sample volumes under strict turnaround times, with vendor lock-in and fragmented software as major obstacles to scaling their digital pathology workflows. Last June, at […]

The post Aiforia: Unlocking diagnostic value at Fimlab with Aiforia® Breast Cancer Suite first appeared on Tissuepathology.com.

Techcyte Fusion® Anatomic Pathology advances digital pathology transformation at Mayo Clinic

Erica Goodpaster — Fri, 17 Jul 2026 11:38:08 +0000

Techcyte and Mayo Clinic: Deployment across Mayo Clinic pathology practices integrates AI-enabled digital pathology with historical pathology images and clinical data in a unified workflow. Mayo Clinic and Techcyte today announced the implementation of Anatomic Pathology (AP) technology, a next-generation digital pathology platform developed through a co-development and intellectual property licensing agreement between the two […]

The post Techcyte Fusion® Anatomic Pathology advances digital pathology transformation at Mayo Clinic first appeared on Tissuepathology.com.

Techcyte Announces Go-Live of Fusion Parasitology Suite at Sonora Quest Laboratories

Erica Goodpaster — Tue, 14 Jul 2026 12:12:09 +0000

OREM, UT, UNITED STATES, July 13, 2026 /EINPresswire.com/ — Techcyte today announced that Sonora Quest Laboratories, one of the largest integrated laboratory systems in the United States, has gone live with the Techcyte Fusion® Parasitology Suite (for research use only). As a joint venture between Banner Health and Quest Diagnostics, Sonora Quest Laboratories plays a key role in delivering […]

The post Techcyte Announces Go-Live of Fusion Parasitology Suite at Sonora Quest Laboratories first appeared on Tissuepathology.com.

Lumito and Navinci initiate pilot project – promising initial results from evaluation of combined technology

Erica Goodpaster — Fri, 10 Jul 2026 12:29:58 +0000

July 9, 2026 – Lumito AB (publ) (“Lumito” or the “Company”) today announces that the Company has initiated a pilot project together with the Swedish biotech company Navinci Diagnostics AB (”Navinci”) to evaluate the possibilities of combining the companies’ respective technologies within advanced tissue analysis. The pilot project aims to combine Lumito’s high-sensitivity image analysis […]

The post Lumito and Navinci initiate pilot project – promising initial results from evaluation of combined technology first appeared on Tissuepathology.com.

Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Survival with BOT+BAL in MSS Metastatic CRC

Erica Goodpaster — Wed, 08 Jul 2026 12:15:19 +0000

Agenus and Noetik: Noetik’s TARIO-2 platform analyzed routine pretreatment H&E images from 113 BOT+BAL-treated patients and identified spatial tumor microenvironment patterns associated with response and survival In a retrospective analysis of refractory MSS metastatic colorectal cancer without active liver metastases, the AI-identified subgroup had a 64% response rate to BOT+BAL, compared with 9% in the […]

The post Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Survival with BOT+BAL in MSS Metastatic CRC first appeared on Tissuepathology.com.